Relief Therapeutics Holding AG (RLFTF)

[Bill B]

Take a look at from this perspective. The market cap will not change with the switch to adrs. Should the company start producing revenue from any source the market cap will reflect the change whether it's denominated in either stock or adrs. Any improvement from current levels would be welcome and I frankly don't expect the share price to recover to the .50 range without an eua and given the complete and total focus of governments everywhere on shots to the exclusion of therapeutics that's not going to happen. A move up to 15 or 20 dollars per adr would be welcome.